Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Invicta Research and Development Center is a specialized biotechnology organization based in Poland, focused on advancing reproductive medicine and genetic diagnostics. The center operates as the research arm of the Invicta Group, integrating clinical practice with cutting-edge laboratory science to improve outcomes in assisted reproductive technology (ART). Their primary expertise lies in the development of preimplantation genetic testing (PGT) for aneuploidies, monogenic diseases, and structural rearrangements. Additionally, the center has pioneered the use of artificial intelligence and machine learning algorithms to enhance embryo selection processes. Through extensive clinical trials and academic collaborations, Invicta R&D Center aims to provide personalized diagnostic solutions for patients struggling with infertility and recurrent pregnancy loss. The facility is equipped with advanced molecular biology tools, including next-generation sequencing (NGS) platforms, to support its robust research pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Invicta Research and Development Center.